Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study
Samuel Dagogo‐Jack; Jie Liu; Roy Eldor; Guillermo Amorin; Jeremy Johnson; Darcy Hille; Yuqin Liao; Susan Huyck; Gregory Golm; Steven G. Terra; James P. Mancuso; Samuel S. Engel; Brett Lauring
Author Information: University of Tennessee Health Science Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.